Dr. Yoshihide Ogawa is an Emeritus Professor, Faculty of Medicine, University of the Ryukyus, Japan. He was a Consultant and Chair, Kidney Disease Center, Tokyo-West Tokushukai Hospital, and Chair in the Department of Urology, Musashino Tokushukai Hospital, Japan. He completed his Ph.D. at KeioUniversity, Tokyo, Japan.
Dr. Yoshihide Ogawa is serving as an Editorial Board Member for numerous scientific journals. He published numerous articles in National and international journals.
Research interests include Urolithiasis, Pediatric Urology and surgical urology, Dialysis, Kidney transplant and kidney cancer.
Piccioni Maria Grazia
Piccioni Maria Grazia
Department:Obstetrics and Gynecology
She is the professor of Obstetrics and Gynecology in the Graduation Course D in Medicine and Surgery at the University of Rome and at the Branch of Benevento of the same University. She is also the professor of Nursing Sciences at the University of Rome Sapienza and at the Branch of Nettuno of the same University. She is also the University Researcher at the Department of Gynecology- Obstetrics and Urological Sciences in the Faculty of Medicine and Surgery, University of Rome Sapienza. She has honored first class in the degree of Medicine and Qualified as Professional Surgeon at the University of Rome Sapienza in 1982. She has honored first class in the specialization of Obstetrics and Gynecology at the University of Rome in 1986.
Ultrasound in Gynaecology and Obstetrics, Prenatal Diagnosis, Transperineal ultrasound in urinary incontinence.
Professor and Director
University/Institute:West China Hospital
Qiang Wei is the Professor, Doctoral Supervisor and Director of Urology department, West China Hospital, SCU, PR China. He was graduate from Fujian University for his Bachelor’s degree in 1984, then he gained his Master’s degree of Urology from West China hospital in 1991 and Master’s degree of Epidemiology from Gadiah Mada University in Indonesia in 1995. At the same time, he is the Committee man of Urology sub-committee on Chinese Medical Association (CMA), director of Urology sub-committee on Sichuan Medical Association. He published about 300 academic papers, and acquired about 5million RMB research funding.
He specializes in minimally invasive surgery in urology oncology, especially robot surgery and laparoscopic surgery, clinical epidemiology and evidence-based medicine in urology. At the same time, he is good at the basis research in prostate cancer and benign prostate hyperplasia.
Kenneth Lynn Muldrew
Associate Professor, USA
Kenneth Lynn Muldrew
Department:Pathology & Immunology
University/Institute:Baylor College of Medicine
Dr. Kenneth L. Muldrew graduated in 1995 with an MPH (disease control) from the University of Texas Health Science Center-School of Public Health in Houston TX where he devoted significant research and study of perinatal HIV infection. In 1999 he graduated from the University of Texas Medical Branch in Galveston, TX with the degree of doctor of Medicine.Over the past 7 years, he has been a section medical director for molecular diagnostic, clinical microbiology, serology and referral testing laboratories at academic medical centers in Ohio, Mississippi, and Texas. He currently is an associate professor at Baylor College of Medicine and the University of Texas-MD Anderson Cancer Center. In addition to being a section medical director, he has been a licensed CLIA Medical director for two laboratories in the Houston area. He was trained in molecular diagnostics, medical microbiology, and general anatomic and clinical pathology at the University of North Carolina-Chapel Hill, Yale University, and Vanderbilt University respectively. He is Board Certified in molecular genetic pathology, medical microbiology, and general clinical pathology by the American Board of Pathology. He is an expert in the areas of general medical microbiology and the molecular diagnostics of infectious diseases. He has spent a significant portion of his time developing and validating new clinical molecular assays in infectious disease, including three clinical projects using next-generation sequencing (NGS). His laboratory was one of the first in the United States to incorporate full-service automation using the BD Kiestra system in the medical microbiology laboratory. He continues to focus on clinical and translational research on implementation of new diagnostic technologies and assays in medical microbiology and molecular diagnostics laboratories. In addition, to test development, next-generation sequencing, and laboratory management issues, He has been intimately involved in the design and implementation of new molecular and medical microbiology laboratories at Yale-New Haven Hospital, the University of Toledo Medical Center, and the University of Mississippi Medical Center.
clinical pathology, Immunology.
Assistant Professor, USA
University/Institute:Wake Forest School of Medicine
Dr. Majid Mirzazadeh is an Assistant professor in the Department of Urology in the Wake Forest School of Medicine, USA. He earned his medical degree in 1989 from Iran University of Medical Sciences in Tehran, where he was ranked the top student in the university. He completed his urology residency and general surgery training at Iran University in 1994 earning the first rank in Iranian Urology Board Exam in the country. He then attended the Institute of Urology and Nephrology in London, where he received a postgraduate degree in urology. Following this training, he attended in UCLA for uro oncology fellowship and then held a postdoctoral research fellowship at the Wake Forest Institute for Regenerative Medicine. He also completed fellowships in female urology and pelvic reconstructive surgery at Wake Forest School of Medicine before joining the urology department in 2009.
His primary research focuses on UTI and characterization of biofilms on urinary tract stones.
His other research interests center on improving the design and safety of clinical and surgical instruments. A pioneer in device development, he invented a syringe capable of safely delivering multiple doses of injection products to patients.
Department:Urological Robotics Surgery
Matteo Ferro. M is an MD PhD, who holds a specialty in Urology. He is an assistant at division of Urology from May 2013. He has been working with prostate cancer biomarkers and coordinates ,at the University of study “Federico II” of Naples, the evaluation of p2Psa and Phi for detection of Prostate cancer at the initial biopsy for the prostate cancer aggressiveness stratification (Grantor : Beckman Coulter, Inc 2012). He has taught the Master of translational medicine, at University Study of Salerno in 2013(PONa3_00138/F1). He is author and co-author of about 60 articles in peer-reviewed journals and he served as a reviewer for several international peer reviewed journals. He is the member of the Italian Society of Urology, Italian Society of Urologic Oncology, and European Association of Urology. He has lectured at more than 30 national and international conferences.
Matteo Ferro. M research interest in Urologic Cancer Surgery, Urological surgery and Oncology.